Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine vs Oxycodone PCA for Postoperative Pain After VATS
NCT07434427Phase 4Recruiting
- Sponsor
- Medical University of Silesia
- Start
- Mar 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine extended-release injection in acute postoperative pain, chronic post-surgical pain (CPSP), sponsored by Medical University of Silesia. Started Mar 2026; status: recruiting.
02
Drugs
buprenorphine extended-release injection
03
Conditions
acute postoperative painchronic post-surgical pain (CPSP)
Beyond the preview
Go deeper on NCT07434427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07434427.